Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.70
Delayed Data
As of Jul 06
 +0.02 / +1.19%
Today’s Change
0.97
Today|||52-Week Range
2.02
-10.05%
Year-to-Date

Today’s Trading

Previous close1.68
Today’s open1.65
Day’s range-- - --
Volume667,573
Average volume (3 months)481,626
Market cap$253.2M
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.01-0.77%
ZGNXZogenix Inc+0.23+1.80%
CORICorium International...+0.66+4.90%
PTXPernix Therapeutics ...+0.27+4.84%
Data as of 07/06/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers